JPM

322.09

+0.02%↑

V

325.53

-1.85%↓

MA

535.42

-2.31%↓

BAC

56.4

-0.23%↓

MS

182.32

+1.33%↑

JPM

322.09

+0.02%↑

V

325.53

-1.85%↓

MA

535.42

-2.31%↓

BAC

56.4

-0.23%↓

MS

182.32

+1.33%↑

JPM

322.09

+0.02%↑

V

325.53

-1.85%↓

MA

535.42

-2.31%↓

BAC

56.4

-0.23%↓

MS

182.32

+1.33%↑

JPM

322.09

+0.02%↑

V

325.53

-1.85%↓

MA

535.42

-2.31%↓

BAC

56.4

-0.23%↓

MS

182.32

+1.33%↑

JPM

322.09

+0.02%↑

V

325.53

-1.85%↓

MA

535.42

-2.31%↓

BAC

56.4

-0.23%↓

MS

182.32

+1.33%↑

Search

Walker & Dunlop Inc

Fermé

SecteurFinance

62.44 -0.95

Résumé

Variation du prix de l'action

24h

Actuel

Min

62.16

Max

63.15

Chiffres clés

By Trading Economics

Revenu

-539K

33M

Ventes

41M

338M

P/E

Moyenne du Secteur

18.546

27.185

Rendement du dividende

4.23

Marge bénéficiaire

9.661

Employés

1,399

EBITDA

-16M

106M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+22.57% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.23%

4.21%

Prochains Résultats

26 févr. 2026

Date du Prochain Dividende

13 mars 2026

Date du Prochain Détachement de Dividende

27 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-606M

2.1B

Ouverture précédente

63.39

Clôture précédente

62.44

Sentiment de l'Actualité

By Acuity

50%

50%

169 / 445 Classement par Finance

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Walker & Dunlop Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 févr. 2026, 17:25 UTC

Acquisitions, Fusions, Rachats

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 févr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 févr. 2026, 23:43 UTC

Market Talk

Gold Falls on Possible Technical Correction -- Market Talk

9 févr. 2026, 23:14 UTC

Market Talk

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 févr. 2026, 22:29 UTC

Market Talk

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 févr. 2026, 22:19 UTC

Market Talk

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 févr. 2026, 22:08 UTC

Market Talk

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 févr. 2026, 22:01 UTC

Résultats

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 févr. 2026, 21:59 UTC

Résultats

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 févr. 2026, 21:59 UTC

Résultats

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 févr. 2026, 21:58 UTC

Résultats

Friedman Industries 3Q Sales $168M >FRD

9 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

9 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 févr. 2026, 21:48 UTC

Résultats

Friedman Industries 3Q EPS 43c >FRD

9 févr. 2026, 21:17 UTC

Résultats

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 févr. 2026, 21:13 UTC

Market Talk

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 févr. 2026, 21:04 UTC

Résultats

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 févr. 2026, 20:30 UTC

Market Talk

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 févr. 2026, 20:02 UTC

Market Talk

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 févr. 2026, 19:42 UTC

Market Talk

Japan's Yield Curve Expected to Flatten -- Market Talk

9 févr. 2026, 19:31 UTC

Market Talk

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 févr. 2026, 19:27 UTC

Market Talk

Gold Climbs Back Over $5,000/oz -- Market Talk

9 févr. 2026, 19:05 UTC

Market Talk

Nike Returns to List of Hottest Brands -- Market Talk

9 févr. 2026, 18:19 UTC

Market Talk

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 févr. 2026, 17:41 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 févr. 2026, 17:31 UTC

Résultats
Acquisitions, Fusions, Rachats

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 févr. 2026, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

9 févr. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 févr. 2026, 17:17 UTC

Market Talk

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 févr. 2026, 17:16 UTC

Résultats

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Comparaison

Variation de prix

Walker & Dunlop Inc prévision

Objectif de Prix

By TipRanks

22.57% hausse

Prévisions sur 12 Mois

Moyen 77.5 USD  22.57%

Haut 80 USD

Bas 75 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

2

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

70.995 / 76.69Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

169 / 445Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.
help-icon Live chat